Menu
FDA · Drug recall

ManukaGuard Medical Grade Manuka Honey Allercleanse Nasal Spray…

March 3, 2021 Class I

Date
March 3, 2021
Risk class
Class I (FDA's definition, 21 CFR 7.3(m): a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death)
Status
Ongoing
Filed by
NDAL Mfg Inc.
Product
ManukaGuard Medical Grade Manuka Honey Allercleanse Nasal Spray, 1.3 FL OZ (40mL) bottle, 270 measured sprays, Distributed by Ndal Laboratories, 449 Alvarado St., Monterey, CA 93940 (bottle); NDAL MFG Inc., 80 Garden Court, Suite 100, Monterey, CA 93940 (carton); UPC 8 58631 00212 8. the Alvarado St. is for the bottle by putting "(bottle); NDAL MFG Inc., 80 Garden Court, Suite 100, Monterey, CA 93940 (carton); UPC 8 58631 00212 8." (according to the label)
Reason
Microbial Contamination of Non-Sterile Products: Product confirmed to have yeast
Distribution pattern
Distributed Nationwide in the USA and Hong Kong
Quantity
4265 bottles
Codes and lots
LOT # 2010045; Best Before 10 2023
Recall started
Dec. 17, 2020
Recall number
D-0269-2021

What should I do? Medicine recall: what to do

Source: FDA · Drug enforcement report, recall number D-0269-2021. The agency record governs; check it and the company before acting.

Report a mistake on this page